Your email has been successfully added to our mailing list.

×
0 0 -0.0130796670630201 -0.0130558858501783 -0.0225921521997621 -0.0154577883472056 -0.0154577883472056 -0.0154577883472056
Stock impact report

Doctor admits disclosing patient info to drugmaker Aegerion [Reuters (UK)]

NOVELION THERAPEUTICS INC COMMON SHARES (NVLN) 
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novelion.com
Company Research Source: Reuters
Doctor admits disclosing patient info to drugmaker Aegerion | Reuters 3 Min Read BOSTON (Reuters) - A Georgia pediatric cardiologist pleaded guilty on Wednesday to wrongfully disclosing information about his young patients to an Aegerion Pharmaceuticals Inc sales representative seeking to identify potential new users of an expensive cholesterol drug. Dr. Eduardo Montana, 55, entered his plea in federal court in Boston after Aegerion, a unit of Novelion Therapeutics Inc, agreed in September to pay $40.1 million to resolve U.S. investigations related to its marketing of the drug, Juxtapid. Montana pleaded guilty to a misdemeanor charge that he wrongfully disclosed patients’ individual identifiable health information. While he faces up to a year in prison, prosecutors have agreed to recommend a term of probation when he is sentenced on June 4. Montana, who practices in Marietta, Georgia, is the second person so far to face charges in the probe. His lawyer declined to comment. According t Show less Read more
Impact Snapshot
Event Time:
NVLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NVLN alerts
Opt-in for
NVLN alerts

from News Quantified
Opt-in for
NVLN alerts

from News Quantified